NCT06080451

Brief Summary

The HEARTS Technical Package was developed by the World Health Organization to address the implementation gap of cardiovascular disease prevention in low- and middle-income countries. Guatemala is a middle-income country that is currently implementing HEARTS. National authorities are interested in exploring how hypertension and diabetes management can be integrated in HEARTS implementation. The objective of this study is to conduct a feasibility and acceptability pilot trial of integrated hypertension and diabetes management based on HEARTS in the publicly funded primary care system in Guatemala.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
964

participants targeted

Target at P75+ for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 3, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

October 6, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 12, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 27, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 27, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

June 19, 2025

Completed
Last Updated

June 19, 2025

Status Verified

June 1, 2025

Enrollment Period

8 months

First QC Date

October 6, 2023

Results QC Date

February 26, 2025

Last Update Submit

June 17, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Score on Feasibility of Intervention Measure (FIM) Questionnaire

    Feasibility will be assessed among Ministry of Health (MOH) participants through the four-item Feasibility of Intervention Measure (FIM) Questionnaire and semi-structured interviews. A Spanish-language version of the FIM will be adapted for this project. Scores will be on a scale of 1 to 5, with 1 being the worst and 5 being the best. The average score for each participant will be used.

    6 months

  • Number of Target Health Districts That Met Enrollment Goals

    This study will be working with two different health districts, one in the west and the other in the east. This measure is the number of districts that met enrollment goals for patients for patients with diabetes (at least 25) and also for patients with hypertension (at least 25). A given patient may have both diabetes and hypertension and thus count toward each benchmark

    6 months

  • Score on Acceptability of Intervention Measure (AIM) Questionnaire

    Acceptability will be assessed among providers through the four-item Acceptability Intervention Measure (AIM) Questionnaire and semi-structured interviews. A Spanish-language version of the AIM will be adapted for this project. Scores will be on a scale of 1 to 5, with 1 being the worst and 5 being the best. The average score for each participant will be used.

    6 months

  • Proportion of Patient Participants With Subsequent Follow-up Visit Within 3 Months

    Proportion of patient participants with subsequent follow-up visit within 3 months in both regions combined.

    3 months

Secondary Outcomes (15)

  • Hypertension Treatment Rate

    6 months

  • Diabetes Treatment Rate

    6 months

  • Proportion of Patient Participants Achieving Glycemic Control

    6 months

  • Proportion Achieving Control of Blood Pressure

    6 months

  • Adoption

    6 months

  • +10 more secondary outcomes

Study Arms (2)

HEARTS implementation - Patients

EXPERIMENTAL

A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the patients whose health markers will be monitored through the study.

Other: Integrated Diabetes and Hypertension Primary Care Model

HEARTS implementation - Providers

EXPERIMENTAL

A trial for 6 months will be carried out in 11 Ministry of Health primary care facilities starting in October 2023. This arm consists of the health care providers who will be administering care to the patient participants.

Other: Integrated Diabetes and Hypertension Primary Care Model - Providers

Interventions

The intervention consists of five components that align with the World Health Organization Technical Package for Cardiovascular Disease Management in primary Health Care. 1. Training health workers on diabetes and hypertension treatment protocols 2. Team-based care and task sharing 3. Strengthening access to medications and diagnostics 4. Electronic medical record system and registry 5. Systems monitoring and feedback of key indicators

Also known as: HEARTS
HEARTS implementation - Patients

The intervention consists of five components that align with the World Health Organization Technical Package for Cardiovascular Disease Management in primary Health Care. 1. Training health workers on diabetes and hypertension treatment protocols 2. Team-based care and task sharing 3. Strengthening access to medications and diagnostics 4. Electronic medical record system and registry 5. Systems monitoring and feedback of key indicators Health care providers will administer this intervention to patient participants and will report on their experience.

HEARTS implementation - Providers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non-pregnant adults aged ≥18 years
  • Diagnoses of type 2 diabetes or hypertension
  • Present for routine care at participating MOH primary health facilities

You may not qualify if:

  • Confirmed or suspected type 1 diabetes
  • Pregnant
  • Are not managed at MOH health centers or health posts
  • Provider/other participants
  • Participation in delivering HEARTS or on the Technical Advisory Committee
  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ministry of Health clinics

San Pablo La Laguna, Departamento de Sololá, Guatemala

Location

Related Publications (2)

  • Wellmann IA, Ayala LF, Rodriguez JJ, Guetterman TC, Irazola V, Palacios E, Huffman MD, Rohloff P, Heisler M, Ramirez-Zea M, Flood D. Implementing integrated hypertension and diabetes management using the World Health Organization's HEARTS model: protocol for a pilot study in the Guatemalan national primary care system. Implement Sci Commun. 2024 Jan 9;5(1):7. doi: 10.1186/s43058-023-00539-8.

    PMID: 38195600BACKGROUND
  • Wellmann IA, Ayala LF, Valley TM, Irazola V, Huffman MD, Heisler M, Rohloff P, Donis R, Palacios E, Ramirez-Zea M, Flood D. Evaluating the World Health Organization's Hearts Model for Hypertension and Diabetes Management: A Pilot Implementation Study in Guatemala. Glob Heart. 2025 Jan 31;20(1):9. doi: 10.5334/gh.1397. eCollection 2025.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2HypertensionCardiovascular Diseases

Interventions

Heart, Artificial

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Prostheses and ImplantsEquipment and SuppliesArtificial OrgansSurgical Equipment

Results Point of Contact

Title
Dr. David Flood
Organization
University of Michigan

Study Officials

  • David Flood, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine

Study Record Dates

First Submitted

October 6, 2023

First Posted

October 12, 2023

Study Start

October 3, 2023

Primary Completion

May 27, 2024

Study Completion

May 27, 2024

Last Updated

June 19, 2025

Results First Posted

June 19, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

This project will produce multiple types of data, including patients' clinical information, health facility assessments, and structured and semi-structured interviews. Deidentified data, analytic code, and data dictionaries will be made available on the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) data repository (https://biolincc.nhlbi.nih.gov/) after the study concludes. Semi-structured interview transcripts and structured questionnaire data will not be shared due to privacy concerns and risk for re-identification.

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations